37 related articles for article (PubMed ID: 25446421)
1. Radiofrequency ablation of lymphoma.
Sudheendra D; Barth MM; Hegde U; Wilson WH; Wood BJ
Blood; 2006 Feb; 107(4):1624-6. PubMed ID: 16254135
[TBL] [Abstract][Full Text] [Related]
2. 2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.
Richard PO; Violette PD; Bhindi B; Breau RH; Gratton M; Jewett MAS; Kapoor A; Pouliot F; Leveridge M; So AI; Whelan TF; Rendon RA; Tanguay S; Finelli A
Can Urol Assoc J; 2023 Jun; 17(6):162-174. PubMed ID: 37310905
[No Abstract] [Full Text] [Related]
3. Thermal Ablation for Renal Cell Carcinoma: Expert Consensus from the Asian Conference on Tumor Ablation.
Park BK; Shen SH; Fujimori M; Wang Y
Korean J Radiol; 2021 Sep; 22(9):1490-1496. PubMed ID: 34448380
[No Abstract] [Full Text] [Related]
4. Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.
Park BK; Shen SH; Fujimori M; Wang Y
Investig Clin Urol; 2021 Jul; 62(4):378-388. PubMed ID: 34190433
[TBL] [Abstract][Full Text] [Related]
5. Update on MRI of Cystic Renal Masses Including Bosniak Version 2019.
Krishna S; Schieda N; Pedrosa I; Hindman N; Baroni RH; Silverman SG; Davenport MS
J Magn Reson Imaging; 2021 Aug; 54(2):341-356. PubMed ID: 33009722
[TBL] [Abstract][Full Text] [Related]
6. CUA guideline on the management of cystic renal lesions.
Richard PO; Violette PD; Jewett MA; Pouliot F; Leveridge M; So A; Whelan TF; Rendon R; Finelli A
Can Urol Assoc J; 2017; 11(3-4):E66-E73. PubMed ID: 28360949
[No Abstract] [Full Text] [Related]
7. Management of Urinoma Formation After Laparoscopic Cryoablation of Renal Cyst.
Li SX; Dagrosa LM; Pais VM
J Endourol Case Rep; 2017; 3(1):10-12. PubMed ID: 28164162
[No Abstract] [Full Text] [Related]
8. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of renal cell carcinoma: a follow up of outcomes.
Curry D; Yassin M; Thwaini A; Pahuja A; Alanbuki AH; Rajan TN; Loan W
Can J Urol; 2014 Feb; 21(1):7135-40. PubMed ID: 24529016
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique?
Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J
Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
Park JJ; Park BK; Park SY; Kim CK
J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
[TBL] [Abstract][Full Text] [Related]
12. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
13. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
14. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
[TBL] [Abstract][Full Text] [Related]
15. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
